Articles by Chelsea Roh

Chelsea Roh is a freelance writer. Her current focus is blockchain technology and cryptocurrency. One could even call her a blockchain "enthusiast." In addition to content writing, she is an experienced SEO and Social Media Strategist. Before moving to Canada, she spent 10+ years marketing and working hands-on in the medical practice industry within the U.S.A.

Red Robin Shares Tank After Q2 Earnings Surface

Aug 2 Chelsea Roh

The Red Robin earnings report released, resulting in the company’s shares tanking over 20% today. Shares of Red Robin are closely on track today for the lowest close since February 2013. Red Robin (NASDAQ:RRGB) Stock ... [Read]

Hydropothecary Corporation partners with Molson Coors

The Hydropothecary Corporation Stock Skyrockets After Coors Partnership

Aug 1 Chelsea Roh

The Hydropothecary Corporation partners with Molson Coors, sending the cannabis company’s stock skyrocketing on both the Canadian and American markets today. According to an official press release, Molson Coors Canada, a Canadian sub-unit of Molson ... [Read]

Progenics Pharmaceuticals receives FDA approval

Progenics Pharmaceuticals’ Stock Gets an 8% Boost After FDA Approval

Jul 31 Chelsea Roh

Progenics Pharmaceuticals receives FDA approval for the first drug to treat rare and extremely life-threatening cancers in patients 12 and older. This approval has boosted the company’s stock exponentially on today’s market. Progenics Pharmaceuticals Receives FDA ... [Read]

AMC Networks Acquires RLJ Entertainment Inc and Stock Flies Today

Jul 30 Chelsea Roh

AMC Networks acquires RLJ Entertainment in what the company is calling a “going-private” merger. AMC Networks Acquires RLJ Entertainment: Merger AMC is acquiring RLJ for around $274 million, and the company will be paying in ... [Read]

Tonix Pharmaceuticals Holding Corp Falls Nearly 70% Today

Jul 27 Chelsea Roh

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) announced this morning that it would be halting its Phase 3 study of its Tonmya drug, which caused its stock price to drop in dramatic fashion. After its twelve-week trial, ... [Read]

OrganiGram Holdings Inc. Eyeing Cash-Flow Positive

Jul 26 Chelsea Roh

OrganiGram Holdings Inc (TSXV:OGI) announced that they expect to be cash-flow positive once Canadian adult recreational marijuana is officially legalized. Organigram Holdings is a leading Canadian producer of medical marijuana that is based in New Brunswick. The ... [Read]

resTORbio Inc’s Positive Phase 2b Trial Results Boost Stock 50%

Jul 25 Chelsea Roh

Shares of resTORbio Inc (NASDAQ:TORC) jumped today after the company announced via press release the results of its phase 2 clinical study. The small biotech company has the drug RTB101, which is used to treat ... [Read]

360 Blockchain Inc Up 7% on Canadian Market

Jul 24 Chelsea Roh

360 Blockchain Inc. (CSE:CODE) just announced that its media platform, Pressland, has chosen the Token Agency as its marketing partner for its initial coin offering (ICO). Token Agency was founded back in January 2017 by ... [Read]

Papa John’s Announces ‘Poison Pill’ and Its Stock Drops Nearly 10 Percent

Jul 23 Chelsea Roh

Papa John’s Internation Inc. (NASDAQ:PZZA) on Sunday adopted a ‘poison pill,’ or a shareholders rights plan that gives them a 15 percent trigger to stop existing stakeholders from amassing a large controlling stake in the ... [Read]

ReWalk Robotics Ltd. Stock Rises Over 70% Amid US Department of Veteran Affairs Policy Revision

Jul 20 Chelsea Roh

The US Department of Veteran Affairs has just revised its national policy on exoskeleton medical device training and procurement for qualifying Veterans with spinal cord injuries (SCI). ReWalk Robotics Ltd. (NASDAQ:RWLK) announced the news today, ... [Read]